Guifeng Wang

1.1k total citations
30 papers, 830 citations indexed

About

Guifeng Wang is a scholar working on Hepatology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Guifeng Wang has authored 30 papers receiving a total of 830 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hepatology, 8 papers in Infectious Diseases and 8 papers in Epidemiology. Recurrent topics in Guifeng Wang's work include Hepatitis C virus research (9 papers), Hepatitis B Virus Studies (8 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Guifeng Wang is often cited by papers focused on Hepatitis C virus research (9 papers), Hepatitis B Virus Studies (8 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Guifeng Wang collaborates with scholars based in China, Japan and United States. Guifeng Wang's co-authors include Jianping Zuo, Wei Tang, Pei‐Lan He, Liping Shi, Fenghua Zhu, Pei‐Zhen Tao, Rujun Zhang, Yudan Ren, Qun‐Fang Liu and Zhuang Li and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Guifeng Wang

28 papers receiving 805 citations

Peers

Guifeng Wang
Guifeng Wang
Citations per year, relative to Guifeng Wang Guifeng Wang (= 1×) peers Eva Kmonı́čková

Countries citing papers authored by Guifeng Wang

Since Specialization
Citations

This map shows the geographic impact of Guifeng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guifeng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guifeng Wang more than expected).

Fields of papers citing papers by Guifeng Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guifeng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guifeng Wang. The network helps show where Guifeng Wang may publish in the future.

Co-authorship network of co-authors of Guifeng Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Guifeng Wang. A scholar is included among the top collaborators of Guifeng Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guifeng Wang. Guifeng Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Guifeng, Keiichi Hiramoto, Ning Ma, et al.. (2024). Immunohistochemical analyses reveal FoxP3 expressions in spleen and colorectal cancer in mice treated with AOM/DSS, and their suppression by glycyrrhizin. PLoS ONE. 19(8). e0307038–e0307038. 2 indexed citations
2.
Li, Huanhuan, et al.. (2022). Analgesic effects of nerve growth factor‐directed monoclonal antibody on diabetic neuralgia in an animal model. FEBS Open Bio. 12(7). 1325–1335. 5 indexed citations
3.
Zhou, Tianhao, Yongmei Wang, Guifeng Wang, et al.. (2022). TROP2 as Patient-Tailoring but Not Prognostic Biomarker for Breast Cancer. OncoTargets and Therapy. Volume 15. 509–520. 8 indexed citations
4.
Ma, Ning, Feng He, Jun Kawanokuchi, Guifeng Wang, & Takenori Yamashita. (2022). Taurine and Its Anticancer Functions: In Vivo and In Vitro Study. Advances in experimental medicine and biology. 1370. 121–128. 18 indexed citations
5.
Zhang, Yanan, Hongqing Zhang, Guifeng Wang, et al.. (2022). Intranasal delivery of replicating mRNA encoding hACE2-targeting antibody against SARS-CoV-2 Omicron infection in the hamster. Antiviral Research. 209. 105507–105507. 6 indexed citations
6.
Wang, Yongmei, Yuexin Li, Yili Chen, et al.. (2022). Tyrphostin A9 protects axons in experimental autoimmune encephalomyelitis through activation of ERKs. Life Sciences. 294. 120383–120383. 3 indexed citations
7.
Chen, Yuning, Yanan Zhang, Renhong Yan, et al.. (2021). ACE2-targeting monoclonal antibody as potent and broad-spectrum coronavirus blocker. Signal Transduction and Targeted Therapy. 6(1). 315–315. 38 indexed citations
8.
Liu, Tingting, Lu Ouyang, Xiaojie Deng, et al.. (2021). Enzyme-linked immunosorbent assays for quantification of MMAE-conjugated ADCs and total antibodies in cynomolgus monkey sera. Journal of Pharmaceutical Analysis. 12(4). 645–652. 7 indexed citations
9.
Wang, Guifeng, Keiichi Hiramoto, Ning Ma, et al.. (2021). Glycyrrhizin Attenuates Carcinogenesis by Inhibiting the Inflammatory Response in a Murine Model of Colorectal Cancer. International Journal of Molecular Sciences. 22(5). 2609–2609. 34 indexed citations
10.
Wang, Guifeng, et al.. (2017). Primary splenic carcinosarcoma with local invasion of chest wall: a rare case. Journal of Zhejiang University SCIENCE B. 18(8). 717–722. 5 indexed citations
11.
Cheng, Yu, et al.. (2016). Structure-based optimization and derivatization of 2-substituted quinolone-based non-nucleoside HCV NS5B inhibitors with submicromolar cellular replicon potency. Bioorganic & Medicinal Chemistry Letters. 26(12). 2900–2906. 12 indexed citations
12.
Tanahashi, Nobuyuki, et al.. (2016). Effect of acupuncture stimulation on rats with depression induced by water-immersion stress. Neuroscience Letters. 618. 99–103. 20 indexed citations
13.
Yang, Li, Yajuan Wang, Haijun Chen, et al.. (2015). Effect of a hepatitis B virus inhibitor, NZ-4, on capsid formation. Antiviral Research. 125. 25–33. 29 indexed citations
14.
Yang, Li, Guifeng Wang, Xiankun Tong, et al.. (2014). Benzimidazole derivative, BM601, a novel inhibitor of hepatitis B virus and HBsAg secretion. Antiviral Research. 107. 6–15. 44 indexed citations
15.
Yang, Li, Liping Shi, Haijun Chen, et al.. (2014). Isothiafludine, a novel non-nucleoside compound, inhibits hepatitis B virus replication through blocking pregenomic RNA encapsidation. Acta Pharmacologica Sinica. 35(3). 410–418. 47 indexed citations
16.
Wang, Guifeng, et al.. (2014). Observation on effect of meridian stimulation on blood oxygenation level of brain by applying Near Infra Red Spectrum (NIRS). World Journal of Acupuncture - Moxibustion. 24(2). 47–51.
17.
Qu, Shi‐Jin, Guifeng Wang, Wenhu Duan, et al.. (2011). Tryptamine derivatives as novel non-nucleosidic inhibitors against hepatitis B virus. Bioorganic & Medicinal Chemistry. 19(10). 3120–3127. 32 indexed citations
18.
Luo, Yu, Li Yang, Chunlan Feng, et al.. (2010). Design and synthesis of novel benzimidazole derivatives as inhibitors of hepatitis B virus. Bioorganic & Medicinal Chemistry. 18(14). 5048–5055. 48 indexed citations
20.
Wang, Guifeng, Liping Shi, & Jianping Zuo. (2008). Anti-hepatitis B virus drugs in clinical and preclinical development. Virologica Sinica. 23(2). 137–145. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026